Polyallelic structural variants can provide accurate, highly informative genetic markers focused on diagnosis and therapeutic targets: Accuracy vs. Precision

Clinical Pharmacology and Therapeutics

Volumn 99, Issue 2, 2016, Pages 169-171

  Roses, A D ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; GENETIC MARKER;

ALZHEIMER DISEASE; ARTICLE; DIAGNOSTIC ACCURACY; DIFFUSE LEWY BODY DISEASE; ENERGY METABOLISM; EPIGENETICS; GENE CONTROL; GENE DELETION; GENE INSERTION; GENE REARRANGEMENT; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC VARIABILITY; HUMAN; INDEL MUTATION; LEWY BODY; PHENOTYPE; PRIORITY JOURNAL; RNA SPLICING; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; ALLELE; GENETIC SCREENING; GENETIC VARIATION; GENETICS; GENOME; STANDARDS; TRENDS;

AGED; ALLELES; ALZHEIMER DISEASE; EPIGENOMICS; GENETIC MARKERS; GENETIC TESTING; GENETIC VARIATION; GENOME; HUMANS; LEWY BODY DISEASE;

EID: 84957308993     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1002/cpt.288     Document Type: Article

References (10)

1. Frazer, K.A., Murray, S.S., Schork, N.J. & Topol, E.J. Human genetic variation and its contribution to complex traits. Nat. Rev. Genet. 10, 241-251 (2009).
2. Naj, A.C. et al. Age-at-onset in late onset Alzheimer disease is modified by multiple genetic loci. JAMA Neurol. 71, 1394-1404 (2014).
3. Crenshaw, D.G. et al. Using genetics to enable studies on the prevention of Alzheimer's disease. Clin. Pharmacol. Ther. 93, 177-185 (2013).
4. Lutz, M.W. et al., editors. TOMM40/APOE variation and age of onset of mild cognitive impairment and dementia in a prospective longitudinal study. Alzheimer's Association International Conference (AAIC); 2015; July 18-23, 2015, Washington, DC.
5. Corder, E. et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 261, 921-923 (1993).
6. Martin, E.R. et al. SNPing away at complex diseases: analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease. Am. J. Hum. Genet. 67, 383-394 (2000).
7. Chang, S. et al. Lipid-and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity. Proc. Natl. Acad. Sci. U. S. A. 102, 18694-18699 (2005).
8. Jack, C.R., Jr. & Holtzman, D.M. Biomarker modeling of Alzheimer's disease. Neuron. 80, 1347-1358 (2013).
9. Lutz, M.W. et al. A CT-rich haplotype in intron 4 of SNCA confers risk for Lewy body pathology in Alzheimer's disease and affects SNCA expression. Alzheimers Dement. 11, 1133-1143 (2015).
10. Roses, A.D. et al. African-American TOMM40'523-APOE haplotypes are admixture of West African and Caucasian alleles. Alzheimers Dement. 10, 592-601 e2 (2014).